Search

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective To explore the effect of linalotide combined with polyethylene glycol electrolytes powder (PEG) on intestinal preparation before colonoscopy in patients with constipation. Methods A total of 175 patients who underwent colonoscopy in the hospital from January to December 2022 were selected, including 58 cases in the control group.59 cases in the study group A, and 58 cases in the study group B. The Boston bowel preparation scale (BBPS) scores, incidence of adverse reactions, willingness to repeat, satisfaction with bowel preparation, and disease detection rate were compared among the three groups. Results There was no statistically significant difference in the total score of BBPS among the three groups (P > 0.05). There was no statistically significant difference in BBPS score of left colon between the study group B and the control group ( P > 0 ), but compared with study group A, the difference was statistically significant P < 0.05). There was no statistically significant difference in the detection rate of lesions among the three groups ( P > 0.05). The incidence of adverse reactions (excluding abdominal pain and fatigue) in the control group was higher than that in the study group A and the study group B, with statistically significant difference ( P < 0.05). However, there was no statistically significant difference between the study group A and the study group B(P > 0.05) The satisfaction with bowel preparation and willingness to repeat in the study group A and the study group B were higher than those in the control group, with statistically significant differences (P < 0.05). However, there was no statistically significant difference between the study group A and the study group B(P > 0.05). Conclusion For constipation groups with difficulty in intestinal preparation, the combination of linalotide and PEG regimen has good intestinal cleaning effects, low incidence of adverse reactions, and can improve patient satisfaction and tolerance. [ABSTRACT FROM AUTHOR]

结直肠癌作为消化系统一种常见的肿瘤, 约占每年新确诊及癌症相关死亡人数的10%, 已成为 世界上第四大致命癌症, 晚期结直肠癌患者不仅生存率低, 而且治疗对个人及社会带来的经济负担也是巨大 的, 因此, 早期的筛查显得尤为重要。结直肠癌筛查方法多种多样, 结肠镜检查是最精准的筛查方法, 结肠镜检 查的精准度与肠道清洁度密切相关, 而饮食准备是肠道准备中的一个重要环节, 其中老年患者, 便秘患者等特 殊人群肠道准备较为困难, 因此, 寻找适合该类人群的饮食准备方案能更好地提高其肠道准备质量, 以及结肠 镜检查的准确性及完成度, 同时提高受检者的体验感及满意度. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective To observe the clinical efficacy and safety of Morinda Officinalis Oligose Capsule in the treatment of functional dyspepsia (FD) accompanied by mild-to-moderate depression，and to investigate its possible action mechanism. Methods The randomized control study was adopted，120 cases of FD accompanied by mild-to-moderate depression were randomly assigned into the trial group (48 cases)，control group (40 cases) and placebo group (32 cases) .The three groups were respectively given Morinda Officinalis Oligose Capsule，escitalopram and placebo for 6 weeks. The Hamilton Depression Scale-17 (HAMD-17) and the Gastrointestinal Symptom Score (GIS) were adopted to evaluate the depression degree and digestive tract symptoms. The plasma 5-hydroxytryptamine (5-HT) level before and after treatment were compared among the three groups. Results Compared with before treatment，the HAMD-17 score，GIS score and plasma 5-HT level after treatment in the trial group and control group were significantly decreased with statistical difference (P <0.05) . Compared with the placebo group，the HAMD-17 score，GIS score and plasma 5-HT level after treatment in the trial group and control group were decreased，the differences were statistically significant (P<0.05) ，while comparing the trial group with the control group，the difference had no statistical significance (P>0.05) . The occurrence rate of adverse reactions was 16.67% in the trial group，22.50% in the control group and 21.88% in the placebo group，the difference had no statistical significance (P >0.05) . Conclusion Morinda Officinalis Oligose Capsule can significantly ameliorate the depression disoder and digestive tract symptoms in FD patients accompanied by mild-tomoderate depression， its effect is similar to that of escitalopram and adverse reactions are similar to placebo， its good clinical effect may have a certain correlation with decreasing the plasma 5-HT level. [ABSTRACT FROM AUTHOR]